Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.
R. Caorsi, A.I. (2020). A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, 18(S2), 14-14.
A national multicentre study on severe paediatric recurrent idiopathic pericarditis treated with IL-1 blockers: appropriateness of the standard of care and pros and cons of anti-IL-1 treatments
M. C. Maggio;
2020-01-01
Abstract
Recurrent pericarditis (RP) is a rare cause of morbidity in children. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and colchicine are the standard of care in adults. Recently, anakinra has been proven to be effective in patients with steroid-dependence and colchicine resistance.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PediatricRheumatology_2020_O025.pdf
accesso aperto
Descrizione: PRES2020_O025
Tipologia:
Versione Editoriale
Dimensione
46.26 kB
Formato
Adobe PDF
|
46.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
